Comparison of Intradermal Injection with Mesotherapy of Botulinum Toxin Type A for Axillary Sweat Reduction: A Preliminary, Prospective, Randomized, Self-controlled Study.
Abstract
[BACKGROUND] Relieving botulinum toxin type A (BoNT-A) injection-related pain is important for hyperhidrosis treatment. Till now, there is no report on the comparison of BoNT-A intradermal injection (BontAintra) and BoNT-A mesotherapy (BontAmeso).
[OBJECTIVES] The purpose of this study was to investigate the effect, duration of efficacy, pain, and patients' satisfaction of BontAintra and BontAmeso.
[METHODS] This preliminary, prospective, randomized, self-controlled study recruited subjects expecting to reduce axillary sweat. The subjects were randomized to receive a 50 U BontAintra on the left axillae and a 50, 60, or 70 U BontAmeso on the right axillae, respectively. The axillary sweat weight and hyperhidrosis severity scale (HDSS) on 2 weeks, 1 months, 4 months, and 6 months post-treatment were measured. The pain, satisfaction, and adverse events (AEs) were compared.
[RESULTS] Thirty-one subjects were enrolled. According to the axillary sweat weight and HDSS, the 70 U BontAmeso generated statistically comparable axillary sweat reduction and duration of efficacy with the 50 U BontAintra. The efficacy of 50 and 60 U BontAmeso was comparable with the 50 U BontAintra on the 2 week follow-up, and the duration of efficacy was significantly shorter. The pain ratings with three dosages of BontAmeso were significantly lower than those with BontAintra. The subjects' satisfaction ratings with BontAmeso were significantly higher than those with BontAintra. No serious AEs occurred.
[CONCLUSIONS] Compared with the 50 U BontAintra, the 70 U BontAmeso generated statistically comparable axillary sweat reduction and duration of efficacy, with significantly lower treatment-associated pain and higher satisfaction.
[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
[OBJECTIVES] The purpose of this study was to investigate the effect, duration of efficacy, pain, and patients' satisfaction of BontAintra and BontAmeso.
[METHODS] This preliminary, prospective, randomized, self-controlled study recruited subjects expecting to reduce axillary sweat. The subjects were randomized to receive a 50 U BontAintra on the left axillae and a 50, 60, or 70 U BontAmeso on the right axillae, respectively. The axillary sweat weight and hyperhidrosis severity scale (HDSS) on 2 weeks, 1 months, 4 months, and 6 months post-treatment were measured. The pain, satisfaction, and adverse events (AEs) were compared.
[RESULTS] Thirty-one subjects were enrolled. According to the axillary sweat weight and HDSS, the 70 U BontAmeso generated statistically comparable axillary sweat reduction and duration of efficacy with the 50 U BontAintra. The efficacy of 50 and 60 U BontAmeso was comparable with the 50 U BontAintra on the 2 week follow-up, and the duration of efficacy was significantly shorter. The pain ratings with three dosages of BontAmeso were significantly lower than those with BontAintra. The subjects' satisfaction ratings with BontAmeso were significantly higher than those with BontAintra. No serious AEs occurred.
[CONCLUSIONS] Compared with the 50 U BontAintra, the 70 U BontAmeso generated statistically comparable axillary sweat reduction and duration of efficacy, with significantly lower treatment-associated pain and higher satisfaction.
[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 합병증 | axillae
|
scispacy | 1 | ||
| 약물 | BontAmeso
→ BoNT-A mesotherapy
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Relieving botulinum toxin type A
|
scispacy | 1 | ||
| 약물 | BoNT-A
→ botulinum toxin type A
|
scispacy | 1 | ||
| 약물 | BontAintra
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | Relieving
|
C0332303
Relieved by
|
scispacy | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | hyperhidrosis
|
C0020458
Hyperhidrosis disorder
|
scispacy | 1 | |
| 기타 | Botulinum Toxin Type A
|
scispacy | 1 | ||
| 기타 | Axillary Sweat
|
scispacy | 1 | ||
| 기타 | BoNT-A
→ botulinum toxin type A
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | left axillae
|
scispacy | 1 | ||
| 기타 | subjects
|
scispacy | 1 |
📑 인용 관계
이 논문이 참조한 문헌 25
- Comparative study between fractional laser assisted drug delivery of botulinum toxin versus botulinu…
- Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topica…
- Mesotherapy with botulinum toxin for the treatment of refractory vascular and papulopustular rosacea…
- Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrati…
- Treatment of Hyperhidrosis: An Update.
- Microneedling Delivery of Botulinum Toxin Versus Intradermal Injection in the Treatment of Facial Hy…
- Fractional CO2 Laser for Transcutaneous Drug Delivery of Onabotulinum Toxin in Palmar Hyperhidrosis.
- Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperh…
- Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidros…
- Cryoanalgesia with a CoolSense Device in Patients Treated with Botulinum Toxin-A for Palmar-Plantar …
- Duration of Efficacy Increases with the Repetition of Botulinum Toxin A Injections in Primary Axilla…
- Development of Botulinum Toxin A-Coated Microneedles for Treating Palmar Hyperhidrosis.
- Results of a 10-year follow-up study of botulinum toxin A therapy for primary axillary hyperhidrosis…
- Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, R…
- Investigation of the Efficacy and Safety of Topical Vibration Anesthesia to Reduce Pain From Cosmeti…
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.